v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Income Statement [Abstract]        
Revenues $ 3,810.0 $ 3,563.5 $ 11,078.7 $ 10,435.9
Cost of revenues 2,701.9 2,538.4 7,844.8 7,416.6
Gross profit 1,108.1 1,025.1 3,233.9 3,019.3
Selling, general, and administrative expenses 611.4 553.1 1,739.6 1,678.4
Amortization of intangibles and other assets 78.7 69.5 232.4 207.4
Restructuring and other charges 15.9 5.9 27.4 16.4
Operating income 402.1 396.6 1,234.5 1,117.1
Interest expense (59.1) (56.0) (175.3) (169.1)
Investment income 1.4 3.5 19.2 11.7
Equity method loss, net (11.0) (5.2) (22.3) (7.2)
Other, net (5.4) (1.9) (22.0) (35.6)
Earnings from operations before income taxes 328.0 337.0 1,034.1 916.9
Provision for income taxes 64.9 75.5 193.9 204.1
Net earnings 263.1 261.5 840.2 712.8
Less: Net earnings attributable to the noncontrolling interest (0.3) (0.4) (0.9) (1.0)
Net earnings attributable to Labcorp Holdings Inc. $ 262.8 $ 261.1 $ 839.3 $ 711.8
Basic earnings per share (in dollars per share) $ 3.24 $ 3.14 $ 10.27 $ 8.54
Diluted earnings per share (in dollars per share) $ 3.22 $ 3.12 $ 10.22 $ 8.48